Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient
Vanesa García-Paz, Carolina Gómez-Farińas, Soledad Sánchez-Sánchez, Andrea Otero-Alonso, Clara Carballas-Vázquez, Leticia Vila-Sexto · 2024
Read Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient by Vanesa García-Paz, Carolina Gómez-Farińas, Soledad Sánchez-Sánchez, Andrea Otero-Alonso, Clara Carballas-Vázquez, Leticia Vila-Sexto (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10809834.txt.
Description
Vanesa García-Paz and co-authors describe, in a 2024 report, a blistering skin disease in a patient in her nineties, triggered by a common antibiotic pairing. The disease, linear IgA dermatosis, is an autoimmune attack on the skin's basement layer. It strikes only a few people per million each year.
Drugs cause over a third of adult cases, often with wider and harsher spread. Diagnosis demands a skin test showing a line of the antibody along the junction under a special microscope. The case adds an example tied to piperacillin-tazobactam, a hospital staple. Recognizing drug triggers matters because stopping the drug is half the cure.
Catalog record
| CREATOR | Vanesa García-Paz, Carolina Gómez-Farińas, Soledad Sánchez-Sánchez, Andrea Otero-Alonso, Clara Carballas-Vázquez, Leticia Vila-Sexto |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |